Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potential.

about

Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.

P2860

Q38581733-20CFE3A2-0151-41EF-AA1C-CFFDEFB0B010

P2860

Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potential.

Item

http://www.wikidata.org/entity/Q38436722

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Biochanin a: understanding the ...... ug-drug interaction potential.

@en

type

Item

label

Biochanin a: understanding the ...... ug-drug interaction potential.

@en

prefLabel

Biochanin a: understanding the ...... ug-drug interaction potential.

@en

P1476

Biochanin a: understanding the ...... ug-drug interaction potential.

@en

P2093

Nuggehally R Srinivas

http://www.w3.org/2001/XMLSchema#string

P2860

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties

Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue.

Protective effects of biochanin A on articular cartilage: in vitro and in vivo studies.

Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.

Effect of biochanin a on serum visfatin level of streptozocin-induced diabetic rats.

The impact of dietary isoflavonoids on malignant brain tumors

Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.

Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.

Feasibility and preliminary efficacy of the effects of flavanoid-rich purple grape juice on the vascular health of childhood cancer survivors: a randomized, controlled crossover trial.

P2888

s13318-015-0279-0

P304

119-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13318-015-0279-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000425611

http://www.w3.org/2001/XMLSchema#string

P698

25903969

http://www.w3.org/2001/XMLSchema#string

Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potential.

about

P2860

P2860

Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potential.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698